About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The aim of our group is to investigate the use of medicines and evaluate its benefit/risk relationship in usual clinical practice. Our group coordinates the Catalan centre of the Spanish System of Pharmacovigilance. Research activities on pharmacology and pharmacoepidemiology are coupled with undergraduate teaching at the Autonomous University of Barcelona Medical School, training of specialists in clinical pharmacology, and continuous education of health professionals on therapeutics.
The group is a Special Group of Research recognized by AGAUR GenCat. It is a partner of “The European Consortium “EU PE&PV Network” (European Pharmacoepidemiology and Pharmacovigilance Network)” and it is part of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). It gives institutional support to the Clinical Research Ethical Committee of the University hospital Vall d’Hebron (UHVH), the Drug and Pharmacotherapeutic Committee of the UHVH, and also to the Drug and Pharmacotherapeutic Committee of the Institut Català de la Salut.
The goal of this project is to strengthen the monitoring of benefit-risk of medicines in Europe by developing innovative methods that will enhance the early detection and assessment of adverse drug reaction from different data sources (clinical trials, spontaneous reporting and observational studies). Our group is responsible for working on the use of national drug utilisation data. The specific tasks are to build and update an inventory of data sources on the consumption of the medicines of interest, to evaluate and disseminate methodologies for drug utilisation studies in order to estimate the potential public health impact of adverse drug reactions.
IP: Joan-Ramon Laporte Roselló, Luisa Ibáñez Mora
IP: -
IP: Victòria Cardona Dahl Collaborators: Maria Antònia Agustí Escasany, Laura Gomez Ganda Funding agency: Instituto de Salud Carlos III Funding: 30250 Reference: PI19/01656 Duration: 01/01/2020 - 30/06/2024
PMID: 37086636 Journal: Multiple Sclerosis and Related Disorders Year: 2023 Reference: Mult Scler Relat Disord. 2023 Apr 17;74:104724. doi: 10.1016/j.msard.2023.104724. Impact factor: Publication type: Paper in international publication Authors: Aldevert, Mireia; Anglada, Elisenda; Arevalo, Maria Jesus; Bascunana, Helena; Curto, Gemma; Feliu, Patricia; Galan, Ingrid; Garcia, Itziar; Garcia, Montserrat; Gonzalo, Lorena et al. DOI: 10.1016/j.msard.2023.104724
PMID: 37870045 Journal: Year: 2023 Reference: Turk J Ophthalmol. 2023 Oct 19;53(5):318-321. doi: 10.4274/tjo.galenos.2023.48672. Impact factor: Publication type: Paper in international publication Authors: Agusti, Antonia; Bertolani, Yann; Buck, Paul; Cereza, Gloria; de Abajo, Francisco J; Garcia, Sandra Banderas; Garcia-Arumi, Claudia; Garcia-Arumi, Jose; Garrell-Salat, Xavier; Macia, Miguel A et al. DOI: 10.4274/tjo.galenos.2023.48672
PMID: 37944280 Journal: Journal of Stroke & Cerebrovascular Diseases Year: 2023 Reference: J Stroke Cerebrovasc Dis. 2023 Nov 7;33(1):107467. doi: 10.1016/j.jstrokecerebrovasdis.2023.107467. Impact factor: Publication type: Paper in international publication Authors: Agudelo, Victor Hugo; Alonso, Javier Robles; Alvarez, Maria Eugenia Vazquez; Amat-Santos, Ignacio J; Andraka, Leire; Anton, Salvador Alvarez; Aquino, Rosa Sanchez; Arellano, Manuel Vizcaino; Arroyo, Jose Ramon Ruiz; Arzamendi, Dabit et al. DOI: 10.1016/j.jstrokecerebrovasdis.2023.107467
PMID: 37951469 Journal: Cirugia espanola Year: 2023 Reference: Cir Esp (Engl Ed). 2023 Nov 9:S2173-5077(23)00192-8. doi: 10.1016/j.cireng.2023.01.008. Impact factor: Publication type: Paper in international publication Authors: Alfonso, Fernando; Casanova-Sandoval, Juan; Fernandez-Portales, Javier; Garcia Del Blanco, Bruno; Garcia-Touchard, Arturo; Gonzalo, Nieves; Hernandez-Garcia, Jose Maria; Jimenez-Mazuecos, Jesus; Lopez Cano, Manuel; Lopez-Pais, Javier et al. DOI: 10.1016/j.cireng.2023.01.008
PMID: 35762253 Journal: EXPERT OPINION ON BIOLOGICAL THERAPY Year: 2022 Reference: Expert Opin Biol Ther. 2022 Jul;22(7):831-842. doi: 10.1080/14712598.2022.2093637. Epub 2022 Jul 4. Impact factor: 4.388 Publication type: Paper in international publication Authors: Antonio, Vallano; Merce, Obach; Antonia, Agusti; Carolina, Iglesias-Lopez et al. DOI: 10.1080/14712598.2022.2093637
PMID: 35795713 Journal: EClinicalMedicine Year: 2022 Reference: EClinicalMedicine. 2022 Jul 1;50:101529. doi: 10.1016/j.eclinm.2022.101529. eCollection 2022 Aug. Impact factor: 0 Publication type: Paper in international publication Authors: Castano, Luis; Borobia, Alberto M; Castillo de la Osa, Maria; Gonzalez-Perez, Maria; Garcia-Perez, Javier; Bertran, Maria Jesus; Campins, Magdalena; Lora, David; Perez-Olmeda, Mayte; Alcami, Jose et al. DOI: 10.1016/j.eclinm.2022.101529
PMID: 35404224 Journal: Journal of Clinical Sleep Medicine Year: 2022 Reference: J Clin Sleep Med. 2022 Jul 1;18(7):1857-1864. doi: 10.5664/jcsm.10016. Impact factor: 4.062 Publication type: Paper in international publication Authors: Sampol, Julia, Saez, Maria, Marti, Sergi, Pallero, Mercedes, Barrecheguren, Miriam, Ferrer, Jaume, Sampol, Gabriel, Vimes Fortis, Alba, Guillen Del Castillo, Alfredo, et al. DOI: 10.5664/jcsm.10016
PMID: 34331263 Journal: INFECTION Year: 2022 Reference: Infection. 2022 Apr;50(2):371-380. doi: 10.1007/s15010-021-01662-1. Epub 2021 Jul 30. Impact factor: 3.553 Publication type: Paper in international publication Authors: Kirkegaard, Cristina, Falco-Roget, Anna, Sanchez-Montalva, Adrian, Valls, Angel, Clofent, David, Campos-Varela, Isabel, Garcia-Garcia, Sonia, Leguizamo, Lina Maria, Sellares-Nadal, Julia, Eremiev, Simeon et al. DOI: 10.1007/s15010-021-01662-1
PMID: 34104210 Journal: Therapeutic Advances in Gastroenterology Year: 2021 Reference: Therap Adv Gastroenterol. 2021 May 30;14:17562848211016567. doi: 10.1177/17562848211016567. eCollection 2021. Impact factor: 4.409 Publication type: Paper in international publication Authors: Campos-Varela, Isabel, Villagrasa, Ares, Simon-Talero, Macarena, Riveiro-Barciela, Mar, Ventura-Cots, Meritxell, Aguilera-Castro, Lara, Alvarez-Lopez, Patricia, Nordahl, Emilie A, Rivera-Esteban, Jesus M, Romero, Alba et al. DOI: 10.1177/17562848211016567
PMID: 33216993 Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY Year: 2021 Reference: Br J Clin Pharmacol. 2021 Jun;87(6):2549-2557. doi: 10.1111/bcp.14665. Epub 2020 Dec 3. Impact factor: 4.34 Publication type: Paper in international publication Authors: Vendrell, Lourdes, Aller, Marta B, Boixareu, Nuria, Garcia-Dolade, Nuria, Diogene, Eduard, Perez, Eulalia, Danes, Immaculada, Bosch, Montserrat, Aguilera, Cristina, Agusti, Antonia et al. DOI: 10.1111/bcp.14665
PMID: 33627229 Journal: MEDICINA CLINICA Year: 2021 Reference: Med Clin (Barc). 2021 Jun 11;156(11):568-572. doi: 10.1016/j.medcli.2021.01.009. Epub 2021 Feb 21. Impact factor: 1.725 Publication type: Paper in national publication Authors: Sans-Pola, Carla, Guillen, Elena, Aguilera, Cristina et al. DOI: 10.1016/j.medcli.2021.01.009
PMID: 33431183 Journal: MEDICINA CLINICA Year: 2021 Reference: Med Clin (Barc). 2021 May 21;156(10):509-514. doi: 10.1016/j.medcli.2020.10.015. Epub 2021 Jan 9. Impact factor: 1.725 Publication type: Paper in national publication Authors: Bosch Ferrer, Montserrat, Rodriguez-Acevedo, Breogan, Riera-Arnau, Judit, Filippi-Arriaga, Francesca et al. DOI: 10.1016/j.medcli.2020.10.015
The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine
The study by physician Emilie Anderssen seeks to optimize the medicalization of people living in nursing homes.
